Burgart LJ - Search Results

1

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Feldstein AE, et al. Among authors: burgart lj. Gastroenterology. 2003 Aug;125(2):437-43. doi: 10.1016/s0016-5085(03)00907-7. Gastroenterology. 2003. PMID: 12891546

2

Cetirizine-induce cholestasis.

Fong DG, Angulo P, Burgart LJ, Lindor KD. Fong DG, et al. Among authors: burgart lj. J Clin Gastroenterol. 2000 Oct;31(3):250-3. doi: 10.1097/00004836-200010000-00016. J Clin Gastroenterol. 2000. PMID: 11034010

3

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.

Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, Lymp JF, Burgart L, Colin P. Lindor KD, et al. Hepatology. 2004 Mar;39(3):770-8. doi: 10.1002/hep.20092. Hepatology. 2004. PMID: 14999696 Clinical Trial.

4

p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma.

Taniai M, Higuchi H, Burgart LJ, Gores GJ. Taniai M, et al. Among authors: burgart lj. Gastroenterology. 2002 Oct;123(4):1090-8. doi: 10.1053/gast.2002.36021. Gastroenterology. 2002. PMID: 12360471

5

Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas.

Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ. Miyoshi H, et al. Among authors: burgart lj. Gastroenterology. 1999 Sep;117(3):669-77. doi: 10.1016/s0016-5085(99)70461-0. Gastroenterology. 1999. PMID: 10464144

6

Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis.

Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ. Natori S, et al. Among authors: burgart lj. J Hepatol. 2001 Feb;34(2):248-53. doi: 10.1016/s0168-8278(00)00089-1. J Hepatol. 2001. PMID: 11281553

7

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.

Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ. Feldstein AE, et al. Among authors: burgart lj. Hepatology. 2004 Jul;40(1):185-94. doi: 10.1002/hep.20283. Hepatology. 2004. PMID: 15239102

8

Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.

Gawrieh S, Papouchado BG, Burgart LJ, Kobayashi S, Charlton MR, Gores GJ. Gawrieh S, et al. Among authors: burgart lj. Liver Transpl. 2005 Oct;11(10):1207-13. doi: 10.1002/lt.20455. Liver Transpl. 2005. PMID: 16184568 Free article.

9

Chronic intestinal pseudoobstruction associated with altered interstitial cells of cajal networks.

Feldstein AE, Miller SM, El-Youssef M, Rodeberg D, Lindor NM, Burgart LJ, Szurszewski JH, Farrugia G. Feldstein AE, et al. Among authors: burgart lj. J Pediatr Gastroenterol Nutr. 2003 Apr;36(4):492-7. doi: 10.1097/00005176-200304000-00016. J Pediatr Gastroenterol Nutr. 2003. PMID: 12658043 No abstract available.

10

Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury.

Baskin-Bey ES, Washburn K, Feng S, Oltersdorf T, Shapiro D, Huyghe M, Burgart L, Garrity-Park M, van Vilsteren FG, Oliver LK, Rosen CB, Gores GJ. Baskin-Bey ES, et al. Am J Transplant. 2007 Jan;7(1):218-25. doi: 10.1111/j.1600-6143.2006.01595.x. Am J Transplant. 2007. PMID: 17227570 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page